Journals / KONURALP TIP DERGİSİ / 2021 / Cilt: 13 - Sayı: 1

The prognostic Evaluation of West Syndrome Patients: A Retrospective Observational Study

West Sendromlu Hastaların Prognostik Değerlendirilmesi: Retrospektif Gözlemsel Çalışma

Pages
149–155
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: Symptomatic etiological factors in West syndrome adversely affect the neurodevelopmental process and subsequent seizure prognosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To determine neurodevelopmental and seizure prognoses in our patients with West syndrome receiving adrenocorticotropic hormone (ACTH) therapy, and to identify the factors affecting these.
📊
Key Findings & Data:Materials methods: We determined the demographic factors, previous seizure histories, ACTH use and response times, and etiological factors of 34 patients diagnosed with West syndrome in our clinic at 3-24 months and receiving ACTH therapy.
💡
Conclusion & Impact:Conclusions: Symptomatic etiological factors in West syndrome adversely affect the neurodevelopmental process and subsequent seizure prognosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:West Sendromu · ACTH Tedavisi · Spazm

Abstract

Objective: To determine neurodevelopmental and seizure prognoses in our patients with West syndrome receiving adrenocorticotropic hormone (ACTH) therapy, and to identify the factors affecting these. Materials methods: We determined the demographic factors, previous seizure histories, ACTH use and response times, and etiological factors of 34 patients diagnosed with West syndrome in our clinic at 3-24 months and receiving ACTH therapy. We also investigated their neurological development and its effect on seizure prognosis. Results: We found a significant relationship between patients experiencing seizures before diagnosis and subsequent seizure prognosis. We also found a later response to ACTH and poorer neurodevelopmental and seizure prognoses in patients with symptomatic etiologies. Global developmental delay was determined in 76% of all cases, and seizures persisted despite antiepileptic drugs in 62%. Conclusions: Symptomatic etiological factors in West syndrome adversely affect the neurodevelopmental process and subsequent seizure prognosis.

Özet

Amaç: ACTH tedavisi alan West sendromlu hastalarımızın ileri dönemdeki nörogelişimsel prognozu ve nöbet prognozunun saptanması ve bunlara katkı sunan faktörlerin belirlenmesidir. Gereç ve Yöntem: Kliniğimizde 3-24.aylarında West sendromu tanısı alarak ACTH tedavisi uygulanan 34 hastanın demografik faktörleri, nöbet şekilleri, öncesindeki nöbet öyküleri, ACTH kullanımı ve yanıt süreleri, etyolojik faktörlerini belirledik. Bunların nörolojik gelişim ve nöbet prognozuna etkisini araştırdık. Bulgular: Hastaların tanı öncesinde nöbeti olmasının ilerideki nöbet prognozu ile ilişkisini anlamlı bulduk. Ayrıca semptomatik etyolojili hastalarda ACTH yanıtını daha geç; nörogelişim ve nöbet prognozunu ise daha kötü saptadık. Tüm hastaların %76’ sında global developmental delay, % 62’sinde antiepileptik ilaclara rağmen devam eden nöbetler belirledik. Sonuç: West sendromunda semptomatik etyolojik faktörler nörogelişimsel süreci ve ileriki dönemdeki nöbet prognozunu olumsuz etkilemektedir.

🔖

Cite This Article

TÜRAY, S., HANCI, F., DILEK, M., KABAKUŞ, N. (2021). The prognostic Evaluation of West Syndrome Patients: A Retrospective Observational Study. KONURALP TIP DERGİSİ, Cilt: 13 - Sayı: 1, 149–155. https://ajindex.com/articles/267658

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Hrachovy RA, Frost JD Jr. Infantile epileptic encephalopathy with hypsarrhythmia (infantile spasms/West syndrome). J Clin Neurophysiol 2003
  2. 20(06):408–425 2. Swaiman KF, Ashwal S, Ferriero DM, Schor NF, Finkel RS, Gropman LA, Pearl PL, Shevell MI. Swaiman’s pediatric neurology 6th ed. 2017 Elsevier 539-542 3. Kaushik JS, Patra B, Sharma S, Yadav D, Aneja S. Clinical spectrum and treatment outcome of West Syndrome in children from Northern India. Seizure. 2013
  3. 617–21. 4. Wheless JW, Gibson PA, Rosbeck KL, Hardin M, O'Dell C, Whittemore V, et al. Infantile spasms (West syndrome): Update and resources for pediatricians and providers to share with parents. BMC Pediatr. 2012
  4. Sehgal R, Gulati S, Sapra S, Tripathi M, Kabra M, Pandey RM. Neurodevelopmental and epilepsy outcome in children aged one to five years with infantile spasms—A North Indian cohort. Epilepsy Res. 2014
  5. 526–34. 6. Riikonen RS. Favourable prognostic factors with infantile spasms. Eur J Paediatr Neurol 2010
  6. 14(01):13–18 7. Anlar B,Yalaz K (1996) Denver II gelişimsel tarama testi Türk çocuklarına uyarlanması ve standardizasyonu el kitabı, Ankara Meteksan Matbası 8. Arzimanoglou A, O’Hare A, Johnston MV, Ouvrier R. Aicardi’s Disease of nervous system in childhood 4th ed. 2018 Mac Keith Press.877-878. 9. Lagae L, Verhelst H, Ceulemans B, De Meirleir L, Nassogne MC, De Borchgrave V, et al. Treatment and long term outcome in West syndrome: The clinical reality. A multicentre follow up study. Seizure. 2010
  7. 159–64. 10. Yılmaz S, Tekgul H, Serdaroglu G, Akcay A, Gokben S. Evaluation of ten prognostic factors affecting the outcome of West syndrome. Acta Neurol Belg. 2016 Dec
  8. 116(4):519-527. 11. Partikian A, Mitchell WG (2010) Neurodevelopmental and epilepsy outcomes in a North American cohort of patients with Infantile spasms. J Child Neurol 25:423–428 12. Araujo AC, Fontenelle LM, Pires L (2011) West syndrome: early remission is not assurance of normal final outcome. Child Care Health Dev 37:261–265 13. Shields WD. Infantile spasms: Little seizures, BIG consequences. Epilepsy Curr. 2006
  9. 63–9. 14. Riikonen R, Infantile Spasms: Outcome in Clinical Studies. 2020 Feb 4. pii: S0887-8994(20)30041-2 15. Knupp K, Coryel J, Nickels K, et al. Response to treatment in a prospective national infantile spasms cohort. Ann Neurol. 2016
  10. 475e484. 16. Lux A, Edwards S, Hancock E, et al. The United Kingdom infantile spasm study comparing vigabatrin with prednisolone or tetracosactide at 14